Surveillance MRI is associated with improved survival in patients with primary sclerosing cholangitis.

Autor: Tan N; Department of Gastroenterology and Hepatology, The Alfred, Melbourne, Australia.; Central Clinical School, Monash University, Melbourne, Australia., Ngu N; Central Clinical School, Monash University, Melbourne, Australia.; Department of Gastroenterology and Hepatology, Monash Health, Melbourne, Australia., Worland T; Department of Gastroenterology and Hepatology, Austin Health, Melbourne, Australia., Lee T; Department of Gastroenterology and Hepatology, St Vincent's Health, Melbourne, Australia., Abrahams T; Department of Gastroenterology and Hepatology, St Vincent's Health, Melbourne, Australia., Freeman E; Department of Gastroenterology and Hepatology, The Alfred, Melbourne, Australia., Hannah N; Department of Gastroenterology and Hepatology, Melbourne Health, Melbourne, Australia.; University of Melbourne, Melbourne, Australia., Gazelakis K; Department of Gastroenterology and Hepatology, Western Health, Melbourne, Australia., Madden RG; Department of Gastroenterology and Hepatology, Royal Adelaide Hospital, Adelaide, Australia., Lynch KD; Department of Gastroenterology and Hepatology, Royal Adelaide Hospital, Adelaide, Australia., Valaydon Z; Department of Gastroenterology and Hepatology, Western Health, Melbourne, Australia., Sood S; Department of Gastroenterology and Hepatology, Melbourne Health, Melbourne, Australia.; University of Melbourne, Melbourne, Australia., Dev A; Central Clinical School, Monash University, Melbourne, Australia.; Department of Gastroenterology and Hepatology, Monash Health, Melbourne, Australia., Bell S; Central Clinical School, Monash University, Melbourne, Australia.; Department of Gastroenterology and Hepatology, Monash Health, Melbourne, Australia., Thompson AJ; Department of Gastroenterology and Hepatology, St Vincent's Health, Melbourne, Australia.; University of Melbourne, Melbourne, Australia., Ding JN; Department of Gastroenterology and Hepatology, St Vincent's Health, Melbourne, Australia.; University of Melbourne, Melbourne, Australia., Nicoll AJ; Central Clinical School, Monash University, Melbourne, Australia.; Department of Gastroenterology and Hepatology, Eastern Health, Melbourne, Australia., Liu K; AW Morrow Gastroenterology and Liver Centre, Royal Prince Alfred Hospital, Sydney, Australia., Pandya K; AW Morrow Gastroenterology and Liver Centre, Royal Prince Alfred Hospital, Sydney, Australia., Gow P; Department of Gastroenterology and Hepatology, Austin Health, Melbourne, Australia.; University of Melbourne, Melbourne, Australia., Lubel J; Department of Gastroenterology and Hepatology, The Alfred, Melbourne, Australia.; Central Clinical School, Monash University, Melbourne, Australia., Kemp W; Department of Gastroenterology and Hepatology, The Alfred, Melbourne, Australia.; Central Clinical School, Monash University, Melbourne, Australia., Roberts SK; Department of Gastroenterology and Hepatology, The Alfred, Melbourne, Australia.; Central Clinical School, Monash University, Melbourne, Australia., Majeed A; Department of Gastroenterology and Hepatology, The Alfred, Melbourne, Australia.; Central Clinical School, Monash University, Melbourne, Australia.

Publikováno v: Hepatology communications [Hepatol Commun] 2024 May 02; Vol. 8 (5). Date of Electronic Publication: 2024 May 02 (Print Publication: 2024).

Serum interleukin-4 is elevated in clinical drug-induced liver injury

Autor: Liu, MN, Au, M., Bishara, M., Worland, T., Con, D., Chew, S., McNiece, A., Gronbaek, H., Sluka, P., Nicoll, AJ

Drug-induced liver injury (DILI) remains a challenging diagnosis due to an absence of specific biomarkers. DILI due to volatile anaesthetics (VA-DILI) is characterised by trifluoroacetyl and CYP2E1 antibodies, but may not be seen for weeks after inju

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::187721ab9a5909c030b461cbec0ad67d

Testosterone is lower in men with non-alcoholic fatty liver disease and alcohol-related cirrhosis and is associated with adverse clinical outcomes.

Autor: Apostolov R; Department of Gastroenterology and Liver Transplant Unit, Austin Health, Melbourne, Victoria, Australia.; Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia., Wong D; Department of Gastroenterology and Liver Transplant Unit, Austin Health, Melbourne, Victoria, Australia.; Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia., Low E; Department of Gastroenterology and Liver Transplant Unit, Austin Health, Melbourne, Victoria, Australia., Vaz K; Department of Gastroenterology and Liver Transplant Unit, Austin Health, Melbourne, Victoria, Australia., Spurio J; Department of Gastroenterology and Liver Transplant Unit, Austin Health, Melbourne, Victoria, Australia., Worland T; Department of Gastroenterology and Liver Transplant Unit, Austin Health, Melbourne, Victoria, Australia., Liu D; Department of Gastroenterology and Liver Transplant Unit, Austin Health, Melbourne, Victoria, Australia., Chan RK; Department of General Medicine, Austin Health, Melbourne, Victoria, Australia., Gow P; Department of Gastroenterology and Liver Transplant Unit, Austin Health, Melbourne, Victoria, Australia.; Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia., Grossmann M; Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia.; Department of Endocrinology, Austin Health, Melbourne, Victoria, Australia., Sinclair M; Department of Gastroenterology and Liver Transplant Unit, Austin Health, Melbourne, Victoria, Australia.; Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia.

Publikováno v: Scandinavian journal of gastroenterology [Scand J Gastroenterol] 2023 Jul-Dec; Vol. 58 (11), pp. 1328-1334. Date of Electronic Publication: 2023 Jun 06.

A home-based, multidisciplinary liver optimisation programme for the first 28 days after an admission for acute-on-chronic liver failure (LivR well): a study protocol for a randomised controlled trial.

Autor: Ngu NL; Department of Gastroenterology and Hepatology, Monash Health, Level 3, 246 Clayton Rd, Clayton, Victoria, 3168, Australia. natalie.ngu@monash.edu.; Faculty of Medicine, Nursing and Health Sciences, Monash University, Wellington Rd, Clayton, Victoria, 3800, Australia. natalie.ngu@monash.edu., Saxby E; Department of Gastroenterology and Hepatology, Monash Health, Level 3, 246 Clayton Rd, Clayton, Victoria, 3168, Australia., Worland T; Department of Gastroenterology and Hepatology, Monash Health, Level 3, 246 Clayton Rd, Clayton, Victoria, 3168, Australia., Anderson P; Department of Gastroenterology and Hepatology, Monash Health, Level 3, 246 Clayton Rd, Clayton, Victoria, 3168, Australia., Stothers L; Department of Gastroenterology and Hepatology, Monash Health, Level 3, 246 Clayton Rd, Clayton, Victoria, 3168, Australia., Figredo A; Hospital in the Home, Level 4, 246 Clayton Rd, Clayton, Victoria, 3168, Australia., Hunter J; Department of Gastroenterology and Hepatology, Monash Health, Level 3, 246 Clayton Rd, Clayton, Victoria, 3168, Australia., Elford A; Department of Gastroenterology and Hepatology, Monash Health, Level 3, 246 Clayton Rd, Clayton, Victoria, 3168, Australia., Ha P; Department of Gastroenterology and Hepatology, Monash Health, Level 3, 246 Clayton Rd, Clayton, Victoria, 3168, Australia., Hartley I; Department of Gastroenterology and Hepatology, Monash Health, Level 3, 246 Clayton Rd, Clayton, Victoria, 3168, Australia., Roberts A; Department of Gastroenterology and Hepatology, Monash Health, Level 3, 246 Clayton Rd, Clayton, Victoria, 3168, Australia., Seah D; Department of Gastroenterology and Hepatology, Monash Health, Level 3, 246 Clayton Rd, Clayton, Victoria, 3168, Australia., Tambakis G; Department of Gastroenterology and Hepatology, Monash Health, Level 3, 246 Clayton Rd, Clayton, Victoria, 3168, Australia., Liew D; Adelaide Medical School, The University of Adelaide, Corner of North Terrace & George St, Adelaide, South Australia, 5000, Australia., Rogers B; Faculty of Medicine, Nursing and Health Sciences, Monash University, Wellington Rd, Clayton, Victoria, 3800, Australia.; Hospital in the Home, Level 4, 246 Clayton Rd, Clayton, Victoria, 3168, Australia., Sievert W; Department of Gastroenterology and Hepatology, Monash Health, Level 3, 246 Clayton Rd, Clayton, Victoria, 3168, Australia.; Faculty of Medicine, Nursing and Health Sciences, Monash University, Wellington Rd, Clayton, Victoria, 3800, Australia., Bell S; Department of Gastroenterology and Hepatology, Monash Health, Level 3, 246 Clayton Rd, Clayton, Victoria, 3168, Australia.; Faculty of Medicine, Nursing and Health Sciences, Monash University, Wellington Rd, Clayton, Victoria, 3800, Australia., Le S; Department of Gastroenterology and Hepatology, Monash Health, Level 3, 246 Clayton Rd, Clayton, Victoria, 3168, Australia.; Faculty of Medicine, Nursing and Health Sciences, Monash University, Wellington Rd, Clayton, Victoria, 3800, Australia.

Publikováno v: Trials [Trials] 2022 Sep 05; Vol. 23 (1), pp. 744. Date of Electronic Publication: 2022 Sep 05.

Utility and limitations of Hepascore and transient elastography to detect advanced hepatic fibrosis in HFE hemochromatosis.

Autor: Ong SY; Bruce Lefroy Centre, Murdoch Children's Research Institute, Melbourne, VIC, Australia.; The University of Melbourne, Melbourne, VIC, Australia.; Department of Gastroenterology, Eastern Health, Box Hill, Victoria, Australia., Khoo T; Department of Gastroenterology, Fiona Stanley Hospital, Murdoch, WA, Australia., Nicoll AJ; Department of Gastroenterology, Eastern Health, Box Hill, Victoria, Australia.; Monash University, Melbourne, VIC, Australia., Gurrin L; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, Carlton, VIC, Australia., Worland T; Monash University, Melbourne, VIC, Australia., Pateria P; Department of Gastroenterology, Fiona Stanley Hospital, Murdoch, WA, Australia., Ramm LE; Hepatic Fibrosis Group, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia., Testro A; Department of Gastroenterology, Austin Health, Heidelberg, VIC, Australia., Anderson GJ; Iron Metabolism Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia., Skoien R; Faculty of Medicine, The University of Queensland, Brisbane, Australia.; Department of Gastroenterology, Royal Brisbane and Women's Hospital, Herston, QLD, Australia., Powell LW; Iron Metabolism Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.; Faculty of Medicine, The University of Queensland, Brisbane, Australia., Ramm GA; Hepatic Fibrosis Group, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia., Olynyk JK; Department of Gastroenterology, Fiona Stanley Hospital, Murdoch, WA, Australia. john.olynyk@health.wa.gov.au.; School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA, Australia. john.olynyk@health.wa.gov.au., Delatycki MB; Bruce Lefroy Centre, Murdoch Children's Research Institute, Melbourne, VIC, Australia.; The University of Melbourne, Melbourne, VIC, Australia.; Victorian Clinical Genetics Services, Parkville, VIC, Australia.

Publikováno v: Scientific reports [Sci Rep] 2021 Jul 19; Vol. 11 (1), pp. 14654. Date of Electronic Publication: 2021 Jul 19.